Profiel
Peter Boyd is currently the President & Chief Executive Officer at Sonnest, Inc. and a Director at Protaryx Medical, Inc. He previously worked as the VP-Business Development & General Counsel at Harpoon Medical, Inc. Boyd holds an MBA from the University of Virginia and an undergraduate degree from The University of North Carolina at Charlotte.
Actieve functies van Peter Boyd
| Bedrijven | Functie | Begin |
|---|---|---|
Sonnest, Inc.
 Sonnest, Inc. Medical SpecialtiesHealth Technology Sonnest, Inc. is a company that specializes in developing a contrast agent called Electrast™. The company is based in Baltimore, MD. The inspiration for Electrast™ began in 2015 through a collaboration between Dr. Wrenn, the company's Chief Scientific Officer, and Dr. Brett Angel, an electrophysiologist at Drexel University. Electrast™ is a voltage-activated ultrasound contrast agent that activates with ultrasound and the heart's local electric field if the heart tissue is perfused and viable. The company was founded in 2019 by Steve Wrenn, Brett Angel. The CEO is Peter Boyd. | Algemeen Directeur | - |
Protaryx Medical, Inc.
 Protaryx Medical, Inc. Medical SpecialtiesHealth Technology Protaryx Medical, Inc. is a medical device company, which develops differentiated transseptal access device that is itended for crossing the atrial septum of the heart to improve, streamline, and facilitate catheter-based. minimally invasive left heart interventional therapies. The company was founded by Terri Burke and James S. Gammie and is headquartered in Baltimore, MD. | Directeur/Bestuurslid | 12-09-2023 |
Eerdere bekende functies van Peter Boyd
| Bedrijven | Functie | Einde |
|---|---|---|
Harpoon Medical, Inc.
 Harpoon Medical, Inc. Medical SpecialtiesHealth Technology Harpoon Medical, Inc. develops surgical services. It offers an image-guided, minimally invasive surgical tool for mitral valve repair that enables surgeons to access and repair the mitral valve in a beating heart via a small incision between the ribs without the need for cardiac arrest or cardiopulmonary bypass. The company was founded by James S. Gammie and Peter Wilson in July 2013 and is headquartered in Baltimore, MD. | Algemeen Adviseur | - |
Opleiding van Peter Boyd
| University of Virginia | Masters Business Admin |
| The University of North Carolina at Charlotte | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Harpoon Medical, Inc.
Harpoon Medical, Inc. Medical SpecialtiesHealth Technology Harpoon Medical, Inc. develops surgical services. It offers an image-guided, minimally invasive surgical tool for mitral valve repair that enables surgeons to access and repair the mitral valve in a beating heart via a small incision between the ribs without the need for cardiac arrest or cardiopulmonary bypass. The company was founded by James S. Gammie and Peter Wilson in July 2013 and is headquartered in Baltimore, MD. | Health Technology |
Protaryx Medical, Inc.
Protaryx Medical, Inc. Medical SpecialtiesHealth Technology Protaryx Medical, Inc. is a medical device company, which develops differentiated transseptal access device that is itended for crossing the atrial septum of the heart to improve, streamline, and facilitate catheter-based. minimally invasive left heart interventional therapies. The company was founded by Terri Burke and James S. Gammie and is headquartered in Baltimore, MD. | Health Technology |
Sonnest, Inc.
Sonnest, Inc. Medical SpecialtiesHealth Technology Sonnest, Inc. is a company that specializes in developing a contrast agent called Electrast™. The company is based in Baltimore, MD. The inspiration for Electrast™ began in 2015 through a collaboration between Dr. Wrenn, the company's Chief Scientific Officer, and Dr. Brett Angel, an electrophysiologist at Drexel University. Electrast™ is a voltage-activated ultrasound contrast agent that activates with ultrasound and the heart's local electric field if the heart tissue is perfused and viable. The company was founded in 2019 by Steve Wrenn, Brett Angel. The CEO is Peter Boyd. | Health Technology |
